Survival of extensively- and pandrug-resistant isolates of Acinetobacter baumannii in soils

被引:15
|
作者
Dekic, Svjetlana [1 ]
Hrenovic, Jasna [1 ]
Durn, Goran [2 ]
Venter, Chantelle [3 ]
机构
[1] Univ Zagreb, Fac Sci, Dept Biol, Zagreb, Croatia
[2] Univ Zagreb, Fac Min Geol & Petr Engn, Zagreb, Croatia
[3] Univ Pretoria, Lab Microscopy & Microanal, Pretoria, South Africa
关键词
Bacteria; Environment; Moisture; pH; Public health; Soil; PALEOSOL;
D O I
10.1016/j.apsoil.2019.103396
中图分类号
S15 [土壤学];
学科分类号
0903 ; 090301 ;
摘要
The extensively- and pandrug-resistant isolates of Acinetobacter baumannii are a leading cause of hospital acquired infections. Aside from reports of A. baumannii in wastewaters influenced by hospital effluents, only two studies reported its detection in soils. The lack of data hinders the assessment of soil as the possible environmental reservoir of A. baumannii, prediction of the behaviour of this emergent pathogen in soils and their potential consequences. This study examined the survival of clinically relevant isolates of A. baumannii in the sterilized and fresh soils of different moisture and pH values. In the alkaline, weakly acid, and strongly acid soil A. baumannii survived for five months, up to 15 days, and up to one hour, respectively. Decrease of moisture below 16 wt% can help in the elimination, but the long-term maintenance of viable A. baumannii was detected in completely dry alkaline soil. Linear regression model confirmed that the pH value of soil is the most important environmental factor, which determines the survival of A. baumannii in soils. Acidification of soil seems a promising method in the remediation of soils contaminated with emerging human pathogen A. baumannii.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
    P. Poulikakos
    G. S. Tansarli
    M. E. Falagas
    European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33 : 1675 - 1685
  • [32] Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
    Poulikakos, P.
    Tansarli, G. S.
    Falagas, M. E.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (10) : 1675 - 1685
  • [33] Control of an Intermittent Outbreak Caused by an Emerging Pandrug-Resistant Acinetobacter baumannii Clone ST457 in a Tertiary Hospital
    Zhang, Chuqiu
    Xu, Tingting
    Ji, Yang
    Zheng, Wenping
    Wu, Jingsong
    Lu, Yuemei
    Li, Huiping
    Chen, Rongchang
    Qiu, Chen
    Zhou, Kai
    INFECTIOUS MICROBES & DISEASES, 2021, 3 (04): : 210 - 213
  • [34] In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam
    VanNatta, Mollie
    Grier, Laurie
    Khan, Muhammad H.
    Cornejo, Paulette Pinargote
    Alam, Mohammad
    Moussa, Samir H.
    Smith, Jennifer G.
    Aitken, Samuel L.
    Malek, Alexandre E.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (10):
  • [35] Rifampin Protects Human Lung Epithelial Cells Against Cytotoxicity Induced by Clinical Multi and Pandrug-resistant Acinetobacter baumannii
    Smani, Younes
    Dominguez-Herrera, Juan
    Pachon, Jeronimo
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (08): : 1110 - 1119
  • [36] Extensively Drug-Resistant Acinetobacter baumannii
    Doi, Yohei
    Husain, Shahid
    Potoski, Brian A.
    McCurry, Kenneth R.
    Paterson, David L.
    EMERGING INFECTIOUS DISEASES, 2009, 15 (06) : 980 - 982
  • [37] The Emergence of Multidrug-Resistant (MDR), Extensively Drug-Resistant (XDR), and Pandrug-Resistant (PDR) In Iraqi Clinical Isolates of Escherichia coli
    Al-Hasani, Halah M. H.
    Al-Rubaye, Dalal S.
    Abdelhameed, Alyaa
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (05): : E469 - E482
  • [38] In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations
    Karakonstantis, Stamatis
    Ioannou, Petros
    Kofteridis, Diamantis D.
    INFECTION, 2022, 50 (03) : 569 - 581
  • [39] In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations
    Stamatis Karakonstantis
    Petros Ioannou
    Diamantis D. Kofteridis
    Infection, 2022, 50 : 569 - 581
  • [40] Potential of the Phage Depolymerase from a Myoviridae Bacteriophage vB_AbaM_IME200 Against Pandrug-Resistant Acinetobacter Baumannii
    Bai, C.
    Liu, Y.
    Mi, Z.
    Tong, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197